Abstract:OBJECTIVE:To provide reference for the rational use of narcotic drugs. METHODS:The utilization of narcotic drugs for inpatients in our hospital during 2012-2014 were collected from HIS,and analyzed statistically in respects of consumption amount,consumption sum,DDDs,B/A,DDC and consumption amount of the different departments,and so on. RESULTS:The quantity and consumption amount of Morphine sulfate sustained-release tablets,Oxycodone hydrochloride sustained-release tablets and Codeine phosphate tablet ranked the first 3 places during 2012-2014. Morphine sulfate sustained-release tablets,Oxycodone hy-drochloride sustained-release tablets and Fentanyl transdermal patch(8.4 mg)steadily occupied the first 3 places in the list of con-sumption sum. In the list of DDDs,Fentanyl transdermal patch and Morphine sulfate sustained-release tablets took up the first 3 places;Morphine hydrochloride injection,Bucinnazine hydrochloride injection and Meperidine hydrochloride injection occupied the last 3 places. B/A value of Morphine sulfate sustained-release tablets and Fentanyl transdermal patch(8.4 mg) in 2012,Oxycodo-ne hydrochloride sustained-release tablets in 2014,Fentanyl transdermal patch(2.5 mg)in 2013 and 2014 were all equal to 1 and synchronized well. Others were all biased. DDC of narcotic drugs kept stable in 3 years,and DDC of Oxycodone hydrochloride sus-tained-release tablets took up the first place,followed by Fentanyl transdermal patch (8.4 mg). Narcotic drugs were consumed in 19 departments,but mainly in the department of oncology and general surgery. In the department of oncology,the consumption amount and sum of oral formulation were both significantly higher than other dosage forms,accounting for more than 88% and 52% respectively. CONCLUSIONS:The variety and dosage form of narcotic drugs could meet the clinical needs and its application is basically reasonable. Besides,the utilization of narcotic drugs in the department of oncology consistent with the basic principles of WHO three steps cancer analgesia treatments.

Analysis on the Utilization of Oral Antitumor Drugs

Analysis on the Trend of Drug Use in 22 Hospitals in Hangzhou Region During the Period from 2002 to 2004

Analysis of the Utilization of Anti-osteoporosis Drugs in Beijing Jishuitan Hospital During 2008-2010

Analysis of the Utilization of Antineoplastic Drugs in 9 Cancer Hospitals of China in 2010

Tracing survey and analysis of usage of antibacterial agents for cancer patients

Analysis of Drug Utilization in Outpatients with Oral Diseases in Our Hospital During 2005～2007

Utilization of the Oral Stasis-eliminating Chinese Patent Medicines in Our Hospital During 2006～2008

Analysis of the Drug Utilization in Outpatients in Stmomatological Hospital

Consumption Analysis of Hospital Antineoplastic Drugs in 6 Cities along Yangtse River Valley During 2004-2006

Utilization of Chinese Herbal Medicines in Our Hospital During 2004-2006

ABC Analysis of Drug Utilization in Peking University Hospital of Stomatology from 2009 to 2012

Analysis of Chinese Herbal Medicines Used in Our Hospital During the Period 2002～2005

Analysis of the Off-label Medication of Antitumor Agents in One Cancer Hospital

Utilization of Chinese Patent Medicines in Our Hospital

Analysis of the Utilization of Narcotic Drugs for Inpatients in Our Hospital from 2012 to 2014

Status and Tendency of Anticancer Antibiotics from 2011 to 2013 in Nan-jing Sample Hospitals

Analysis on Application of Adjuvant Drugs in Stomatology Hospital of Peking University During 2014-2016

Analysis of the Utilization of TCM Injections in Our Hospital from 2008 to 2010

Analysis of Application Frequency of Liver Protective Drugs Used in Beijing Cancer Hospital During 2003

Survey and analysis of nutrient support drug utilization in cancer patients

Utilization of oral antihypertensive drugs in Beijing University Hospital